Open AccessComparisons Between PET With 11C-Methyl-l-Methionine and Arterial Spin Labeling Perfusion Imaging in Recurrent Glioblastomas Treated With Bevacizumab
Author(s) -
Teruhiko Beppu,
Yuichi Sato,
Toshiaki Sasaki,
Kazunori Terasaki,
Fumio Yamashita,
Makoto Sasaki,
Kuniaki Ogasawara
Publication year - 2019
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000002417
Subject(s) - medicine , bevacizumab , nuclear medicine , arterial spin labeling , receiver operating characteristic , perfusion scanning , glioblastoma , perfusion , positron emission tomography , radiology , chemotherapy , cancer research
The aim of this study was to clarify whether arterial spin labeling (ASL) perfusion imaging can assess biological effects from bevacizumab (BEV) therapy as reliably as PET with C-methyl-L-methionine (C-met-PET).